2 weeks Ago By Defense World Staff
AC Immune SA ( NASDAQ:ACIU – Get Free Report ) saw a large increase in short interest in the month of October. As of October 31st, there was short interest totalling 984,500 shares, an increase of 23.5% from the October 15th total of 796,900 shares.
Approximately 1.6% of the company’s stock are sold short. Based on an average trading volume of 92,100 shares, the short-interest ratio is currently 10.
7 days. Wall Street Analysts Forecast Growth ACIU has been the topic of a number of recent research reports. HC Wainwright restated a “buy” rating and issued a $16.
00 price objective on shares of AC Immune in a report on Wednesday, November 6th. StockNews.com downgraded AC Immune from a “buy” rating to a “hold” rating in a research note on Tuesday, October 1st.
Check Out Our Latest Stock Analysis on AC Immune Institutional Inflows and Outflows AC Immune Price Performance Shares of AC Immune stock opened at $3.55 on Friday. The stock has a market cap of $351.
24 million, a price-to-earnings ratio of -7.72 and a beta of 1.28.
AC Immune has a 1 year low of $2.25 and a 1 year high of $5.14.
The firm’s 50-day moving average is $3.27 and its 200 day moving average is $3.47.
About AC Immune ( Get Free Report ) AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectively interact with misfolded proteins that are common in a range of neurodegenerative diseases. Featured Stories Five stocks we like better than AC Immune Dividend Capture Strategy: What You Need to Know 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness Mouse Rising: The Iger Investment Pays Off for Disney Investors Following Congress Stock Trades Can CAVA Stock Be the Next Chipotle? Earnings Can Help Receive News & Ratings for AC Immune Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AC Immune and related companies with MarketBeat.
com's FREE daily email newsletter ..
